Baruch S. Blumberg Institute Hosts 16th Annual Regional Biotech Conference
100 local leaders in life science and biotechnology to share successes and opportunities in biotech
DOYLESTOWN, Pa. (November 2016) - The Baruch S. Blumberg Institute, the research arm of the Hepatitis B Foundation, will host the 16th Annual Regional Biotechnology Conference, themed “Incubating Innovation,” on Friday, November 18 at its headquarters at the Pennsylvania Biotechnology Center in Doylestown, Pennsylvania. The area’s life science and biotechnology leaders will meet to share success stories and discuss biotech opportunities.
As a part of the program, Min Gao, Ph.D., a Senior Research Fellow at Arbutus Biopharma and Adjunct Professor of the Blumberg Institute, will be inducted into the PA Biotech Center’s “Drug Inventors Wall of Fame” in recognition of his contribution to inventing the hepatitis C drug, Daclatasvir (Daklinza™).
The biotech conference will be co-moderated by Wayne Yetter, founding CEO of AstraMerck and former CEO of Novartis Pharmaceuticals U.S., and William Kinney, Ph.D., Director of Natural Products at the Blumberg Institute.
The Keynote Speaker is Sean O’Sullivan, Founder and Managing Director of SOSV, an accelerator-focused venture capital firm. Mr. O'Sullivan will address “Accelerating Innovation: How Accelerators are enabling a new dawn in life sciences, biotech and connected devices.”
Additional speakers include Timothy Block, Ph.D., President and Co-founder of the PA Biotech Center and President of the Hepatitis B Foundation and the Baruch S. Blumberg Institute; Kuldeep Neote, Ph.D., Senior Director at J&J Innovation Center-Boston; and Christopher Laing, Ph.D., Vice President, Science & Technology, University City Science Center.
This year’s Premier Sponsor is Univest Bank and Trust Co. The event is scheduled on Friday November 18 from 2 p.m. to 5 p.m. Registration is $100 and can be completed at www.blumberginstitute.org.
About the Baruch S. Blumberg Institute: The Baruch S. Blumberg Institute is an independent, nonprofit research institute established in 2003 by the Hepatitis B Foundation to conduct discovery research and nurture translational biotechnology in an environment conducive to interaction, collaboration and focus. It was renamed in 2013 to honor Baruch S. Blumberg, who won the Nobel Prize for his discovery of the hepatitis B virus and co-founded the Hepatitis B Foundation. To learn more, visit www.blumberginstitute.org.
About the Pennsylvania Biotechnology Center: The Pennsylvania Biotechnology Center of Bucks County offers state-of-the-art laboratory and office space to nonprofit research companies and biotech companies. Established by the Hepatitis B Foundation and managed by the Baruch S. Blumberg Institute, the Center was funded in part by the Commonwealth of Pennsylvania. The facility opened in 2006 in a formerly abandoned warehouse and has since grown to encompass 110,000 square feet on a 10-acre campus. To learn more, visit www.pabiotechbc.org.